If you have not already registered for Full Text Access to The Journal, then visit our registration page.
Many supplements are available to the general public for a limited time on our SuppleNet page.


Monoamine Oxidase Inhibitors Revisited:
Their Role in Depressive Disorders

CME Background Information


4 The Varied Clinical Presentations of Major Depressive Disorder. A. John Rush
[PDF] [Abstract]

11 Recognition and Diagnosis of Atypical Depression. Michael E. Thase
[PDF] [Abstract]

17 Prevalence and Management of Treatment-Resistant Depression. Charles B. Nemeroff
[PDF] [Abstract]

26 Safety and Tolerability of Antidepressants: Weighing the Impact on Treatment Decisions. Alan F. Schatzberg
[PDF] [Abstract]

35 Revisiting Monoamine Oxidase Inhibitors. K. Ranga Krishnan
[PDF] [Abstract]

42 Dietary Restrictions and Drug Interactions With Monoamine Oxidase Inhibitors: The State of the Art. Mark Hyman Rapaport
[PDF] [Abstract]

CME Section

47 Instructions and Posttest.

48 Registration Form and Evaluation.